Thursday May 25th 2017

Archive for April, 2012

Liberation procedure changes woman’s life

Liberation procedure changes woman’s life

Whitney Murray beamed as she made her way along Borland Street toward Lawrence Avenue on Sunday morning. Surrounded by supporters wearing matching t-shirts, the 22-year-old Orillia woman ¬– once housebound due to multiple sclerosis – was walking at a comfortable clip. [Read More]

Appeal board rejects MS treatment claim

Appeal board rejects MS treatment claim

A tribunal has rejected an Eastern Ontario woman’s bid to force the Ontario Health Insurance Plan to pay for a controversial treatment that relieved her multiple sclerosis symptoms. Judy Butcher, a 48-year-old resident of Jasper, Ont., near Merrickville, paid $7,000 for [Read More]

Federal government moves CCSVI study forward

Federal government moves CCSVI study forward

The benefits of MS Liberation Therapy have been touted by Saskatchewan residents who’ve travelled the globe to have it. They say it makes a world of difference in their symptoms. Now, the federal government has made another step towards their own trial here at home. A [Read More]

 Page 1 of 3  1  2  3 »

Latest Topics

Study finds variations among hospitals in transitioning stroke patients from treatment to comfort care

Study finds variations among hospitals in transitioning stroke patients from treatment to comfort care

Hospitals vary widely in how often they transition people with strokes from active treatment to comfort or hospice care [Read More]

Roche investigating case of patient illness after taking MS drug

Roche investigating case of patient illness after taking MS drug

ZURICH (Reuters) - A person in Germany treated with Roche ’s new multiple sclerosis drug Ocrevus has been diagnosed [Read More]

MS Study Alert: Share Your Thoughts About MS Research

MS Study Alert: Share Your Thoughts About MS Research

/About-the-Society/News/MS-Study-Alert-Share-Your-Thoughts-About-MS-Resea [Read More]

Mallinckrodt begins enrolment in Phase IV trial of HP Acthar gel for RRMS

Mallinckrodt begins enrolment in Phase IV trial of HP Acthar gel for RRMS

UK-based specialist pharmaceutical firm Mallinckrodt has begun patient enrolment in the Phase IV OPTIONS clinical trial [Read More]

First Results Announced from Second Phase III Trial of Oral Ozanimod in People with Relapsing MS

First Results Announced from Second Phase III Trial of Oral Ozanimod in People with Relapsing MS

/About-the-Society/News/First-Results-Announced-from-Second-Phase-III-Tria [Read More]